The registry names the sponsor, never the CRO

We have spent several articles pulling worker-relevant signals out of the public trial registry: why trials die, where they run, who sponsors them. There is one thing the registry stubbornly will not tell you, and the gap is worth a piece of its own, because it is the same blind spot that hides clinical research layoffs. The registry records who paid for a trial. It almost never records who actually ran it.

The numbers

Search the roughly 131,000 industry trials for the big contract research organizations, the companies that actually staff and run these studies, and they barely appear:

• Parexel: about 354 records
• Syneos Health: about 185
• PPD: about 183
• IQVIA: about 173
• ICON: about 170
• Medpace: about 102
• Fortrea: about 31
• Labcorp: about 20

IQVIA is the largest CRO on earth, running an enormous share of the world's clinical trials, and it is named in roughly 173 of 131,000 industry records. That is about one tenth of one percent. The CROs that do most of the actual work of clinical research are, as a matter of public record, nearly invisible in it.

Why the CRO disappears

The registry lists the sponsor, the company whose drug is being tested, because that is who holds regulatory responsibility for the trial. The CRO is the contractor the sponsor hires to run it, and that commercial relationship is not part of the required public record. So a trial that is designed, monitored, managed, and analyzed almost entirely by IQVIA or ICON staff shows up in the registry under the sponsor's name, with no trace of the thousands of CRO professionals who did the work.

Think about what that means. The people reading this site, the CRAs, programmers, data managers, and biostatisticians at the big CROs, do the work recorded in half a million public trials, and their employers are scrubbed from the record by design. Your industry is documented in extraordinary public detail, and the part of it you work in is the part that does not show.

The same gap, everywhere

This is the exact pattern we found in the layoff filings. The public WARN record captures the manufacturing and preclinical companies with physical sites and misses the distributed CRO workforce. The public trial registry captures the sponsors and misses the CROs that staff the studies. In both cases, the official record is real, detailed, and structurally blind to the clinical research workforce specifically. The systems were built to track drugs and companies, not the people who develop them.

Why this is the argument for the survey

Put the two blind spots together and the conclusion is hard to avoid. The government tracks the trials but not who runs them. The government tracks mass layoffs but not the distributed cuts. Neither tracks pay at the level that would let you negotiate. On the questions that matter most to a clinical research career, which CRO is good to work for, what it pays, whether it is cutting, the vast public data apparatus is silent by design.

That silence is the entire reason this community exists. The one source that can fill it is the people doing the work, reporting anonymously what no filing and no registry records. The trial registry is a remarkable public asset, and it still cannot see you. The survey can. Add your datapoint, and become the record the system leaves blank.